Agilon Health is aiming for a valuation of up to $9 billion in its initial public offering (IPO), the healthcare platform said on Wednesday, joining a clutch of companies looking to cash in on the record run in U.S. capital markets.
The company said it planned to raise more than $1 billion in its IPO by selling 46.6 million shares at a price range of $20 and $23 per share. Founded in 2016, Agilon health provides a care platform for primary care physicians.
The company will list on the New York Stock Exchange under the symbol “AGL,” it said in a filing. JP Morgan, Goldman Sachs and BofA are among the underwriters for the offering.
Reporting by Niket Nishant and Mrinalika Roy in Bengaluru; Editing by Aditya Soni
Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.